Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Unknown 7Recruiting 5Completed 5Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 295INDUSTRY 261NIH 20OTHER_GOV 5NETWORK 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Dermatologic 1

Conditions

Neoplasms 2Uveal Melanoma 1Stomach Neoplasms 1Sarcopenia 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Esophageal Squamous Cell Carcinoma 1Diabetes Mellitus, Insulin-Dependent, 12 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 15Cisplatin 12Radiotherapy 11Metformin 8Fluorouracil 8Capecitabine 8Paclitaxel 7Oxaliplatin 7Exercise 7Indocyanine Green 6Docetaxel 6Cyclophosphamide 6Control Groups 6Surveys and Questionnaires 5Standard of Care 5Nivolumab 5Letrozole 5Irinotecan 5pembrolizumab 4durvalumab 4Zoledronic Acid 4Vinorelbine 4Saline Solution 4Preoperative Exercise 4Magnetic Resonance Spectroscopy 4Leucovorin 4Ifosfamide 4Gefitinib 4Drug Therapy 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × OTHER_GOV × Nivolumab × Clear all
NCT07192926 2026-02-20

SARCO-CTI

Ankara Etlik City Hospital

Completed
131 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

NCT03914443 2025-05-31

A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma

National Cancer Center, Japan

Phase 1 Completed
37 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04463368 2025-03-28

SCANDIUM II

Vastra Gotaland Region

Phase 1 Completed
18 enrolled
Dermatologic

Uveal Melanoma

NCT03507699 2023-04-18

Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer

Sheba Medical Center

Phase 1 Completed
19 enrolled
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Colonic Neoplasms

NCT02999295 2019-08-21

A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer

National Cancer Center, Japan

Phase 1/2 Completed
46 enrolled
Gastrointestinal

Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡